Okuda K

No ORCID on file · 8 papers in corpus
lab-animal 2024
Journal for immunotherapy of cancer ·doi:10.1136/jitc-2023-008441

BACKGROUND: Enhanced glucose metabolism has been reported in many cancers. Glucose-6-phosphate dehydrogenase (G6PD) is a rate-limiting enzyme involved in the pentose phosphate pathway, which maintains NADPH levels and protects cells from ox…

lab-animal 2020
Scientific reports ·doi:10.1038/s41598-020-58109-0

Equine endometrial fibrosis (endometrosis) is described as a degenerative chronic condition in the uterus. Its characteristic feature is excessive deposition of extracellular matrix (ECM) components around the endometrial glands and stroma.…

lab-animal 2019
Cytokine ·doi:10.1016/j.cyto.2019.154767

Equine endometrosis (endometrial fibrosis) is a degenerative chronic process that occurs in the uterus of the mare and disturbs proper endometrial function. Fibrosis is attributed to excessive deposition of extracellular matrix (ECM) compon…

other 2017
Asian journal of endoscopic surgery ·doi:10.1111/ases.12412

INTRODUCTION: The aim of this study was to investigate the effect of laparoscopic endometriotic cystectomy and vaporization on ovarian reserve. METHODS: We prospectively analyzed the serum level of anti-Mullerian hormone (AMH) in 62 patien…

other 2014
Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2014.03.008

STUDY OBJECTIVE: To evaluate how endometriotic cystectomy and vaporization affect ovarian reserve after conservative surgery. DESIGN: Prospective study (Canadian Task Force classification II-1). SETTING: Hokusetsu General Hospital. PATIE…

other 2013
Endocrine research ·doi:10.3109/07435800.2013.774011

INTRODUCTION: GPR30 is a seven-transmembrane G protein-coupled estrogen receptor that regulates endometrial cellular responses to estrogen. GPR30 is often highly expressed in cancer cells from aggressive tumors. The aim of this study was to…

other 2012
Journal of ovarian research ·doi:10.1186/1757-2215-5-31

BACKGROUND: The resistance of endometriotic tissue to progesterone can be explained by alterations in the distribution of progesterone receptor (PR) and estrogen receptor (ER) isoforms. The aims of this study were to examine the expressions…

other 1988
Nihon Sanka Fujinka Gakkai zasshi

The LHRH agonist buserelin was administered intranasally to eight patients with endometriosis in doses of 300, 600 or 900 micrograms/day for six months. In all patients buserelin clearly suppressed ovulation. In the patients treated with 90…